PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.\', \'Department of Clinical Haematology, Monash Health, Melbourne, VIC, Australia.\', \'Haematology/Transfusion Medicine, National Health Service (NHS) Blood and Transplant, Oxford, United Kingdom; and.\', \'Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1182/blood.2020008903
?:doi
?:hasPublicationType
?:journal
  • Blood
is ?:pmid of
?:pmid
?:pmid
  • 33202419
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.434
?:rankingScore_hIndex
  • 410
is ?:relation_isRelatedTo_publication of
?:title
  • How should we use convalescent plasma therapies for the management of COVID-19?
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33202419>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33202419>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all